子類別 會議論文/會議摘要 [7/13] 期刊論文 [42/42] 鄰近社群 伍素瑩 [52/65] 其他 [58/60] 夏克山 [76/98] 岳嶽 [29/32] 張仲明 [7/9] 張俊彥 [18/18] 張竣評 [21/26] 徐祖安 [170/215] 李秀珠 [75/105] 李靜琪 [23/24] 林書玉 [19/20] 洪明秀 [31/40] 潘秀玲(2009-2013) [16/17] 王文傑 [13/15] 王鴻俊 [7/7] 石全(2014-2017) [35/39] 童俊維 [23/23] 紀雅惠 [21/25] 翁紹華 [22/24] 莊宏 [1/1] 葉修華 [24/25] 葉燈光 [133/152] 蔣維棠 [41/66] 謝興邦 [171/231] 趙宇生(2002-2013) [120/212] 鄒倫 [28/29] 陳志豪 [31/52] 陳新(2002-2015) [53/67] 陳炯東 [180/212] 顏婉菁 [6/7] 許明珠(1997-2001) [3/10] 陳淑貞(1998-2001) [3/11] 陳華鍵(1997-2001) [9/9] 社群統計 近3年內發表的文件:6(10.91%) 含全文筆數:49(89.09%) 文件下載次數統計 下載大於0次:49(100.00%) 下載大於100次:49(100.00%) 檔案下載總次數:22788(0.43%) 最後更新時間: 2024-11-28 12:20 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Lysosomal-targeted doxorubicin deli... How to deal with frenemy NRF2: Targ... Synthesis and structure–activity re... Pilot study: Nutritional and precli... A novel NRF2/ARE inhibitor gossypol... Discovery and development of a nove... Type-3 hyaluronan synthase attenuat... Two new chromones and a new coumari... Xanthine derivatives reveal an allo... c-MYC-directed NRF2 drives malignan...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目26-50 / 55. (共3頁) << < 1 2 3 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2018-04	4-Bromophenylhydrazinyl benzenesulfonylphenylureas as indoleamine 2,3-dioxygenase inhibitors with in vivo target inhibition and anti-tumor efficacy	Bioorganic Chemistry. 2018 Apr;77:600-607.
2017-12	Enhanced B-Raf-mediated NRF2 gene transcription and HATs-mediated NRF2 protein acetylation contributes to ABCC1-mediated chemoresistance and glutathione-mediated survival in acquired topoisomerase II poison-resistant cancer cells	Free Radical Biology and Medicine. 2017 Dec;113:505-518.
2017-08	Hypoxia-induced downregulation of DUSP-2 phosphatase drives colon cancer stemness	Cancer Research. 2017 Aug;77(16):4305-4316.
2017-07	Drug repurposing for chronic myeloid leukemia: In silico and in vitro investigation of DrugBank database for allosteric Bcr-Abl inhibitors	Journal of Biomolecular Structure and Dynamics. 2017 Jun;35(8):1833-1848.
2017-07	Design, synthesis, and evaluation of thiazolidine-2,4-dione derivatives as a novel class of glutaminase inhibitors	Journal of Medicinal Chemistry. 2017 Jul;60(13):5599-5612.
2016-12	Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation	Oncotarget. 2016 Dec;7(52):86239-86256.
2016-12	Phenyl benzenesulfonylhydrazides: Selective indoleamine 2,3-dioxygenase inhibitors with potent in vivo pharmacodynamic activity and antitumor efficacy	European Journal of Cancer. 2016 Dec;68(Suppl. 1):S83-S84.
2016-08	Desferal regulates hCtr1 and transferrin receptor expression through Sp1 and exhibits synergistic cytotoxicity with platinum drugs in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo	Oncotarget. 2016 Aug;7(31):49310-49321.
2016-07-01	MPT0B098, a microtubule inhibitor, suppresses JAK2/STAT3 signaling pathway through modulation of SOCS3 stability in oral squamous cell carcinoma	PLoS ONE. 2016 Jul 1;11(7):Article number e0158440.
2016-01	2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibition	Organic and Biomolecular Chemistry. 2016 Jan;14(2):716-723.
2016-01	Phenyl benzenesulfonylhydrazides exhibit selective Indoleamine 2,3-Dioxygenase inhibition with potent in vivo pharmacodynamic activity and antitumor efficacy	Journal of Medicinal Chemistry. 2016 Jan;59(1):419-430.
2015-12	Novel oxime-bearing coumarin derivatives act as potent Nrf2/ARE activators in vitro and in mouse model	European Journal of Medicinal Chemistry. 2015 Dec;106:60-74.
2015-09	O6-Methylguanine DNA methyltransferase repairs platinum-DNA adducts following cisplatin treatment and predicts prognoses of nasopharyngeal carcinoma	International Journal of Cancer. 2015 Sep;137(6):1291-1305.
2015-08	Antimitotic and antivascular activity of heteroaroyl-2-hydroxy-3,4,5-trimethoxybenzenes	Bioorganic and Medicinal Chemistry. 2015 Aug;23(15):4230-4236.
2015-08	Novel Nrf2/ARE activator, trans-coniferylaldehyde, induces a HO-1-mediated defense mechanism through a dual p38alpha/MAPKAPK-2 and PK-N3 signaling pathway	Chemical Research in Toxicology. 2015 Aug ;28(9):1681-1692.
2015-08	Optimization of furanopyrimidine-based kinase inhibitors: Identification of a BTK kinase inhibitor for the treatment of B cell lymphoma	Abstracts of Papers of the American Chemical Society. 2015 Aug;250:Meeting Abstract 180.
2015-05	Mechanistic basis of a combination D-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo	Biochemical Pharmacology. 2015 May;95(1):28-37.
2015-05	Enhanced antitumor activity of rapamycin and genipin, a UCP-2 inhibitor, in lung cancer	Journal of Clinical Oncology. 2015 May;33(15, Suppl.):e13595.
2015-01	Two new labdane-type diterpene acids from the wood of cunninghamia konishii	Helvetica Chimica Acta. 2015 Jan;98(1):123-127.
2014-11	Discovery of multiple kinases inhibitors, DBPR114, as the novel anti-cancer agent	European Journal of Cancer. 2014 Nov;50(Suppl. 6):92-93.
2014-11	Cytokine induces MIR-424 expression and modulates SOCS2/STAT5 signaling pathway in oral cancer	European Journal of Cancer. 2014 Nov;50(Suppl. 6):147.
2014-10	Copper-chelator exerts synergistic interaction with platinum drugs through modulating copper transporters in oxaliplatin-resistant human gastric cancer cell	Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 3753.
2014-05	Azaindolylsulfonamides, with a more selective inhibitory effect on histone deacetylase 6 activity, exhibit antitumor activity in colorectal cancer HCT116 cells	Journal of Medicinal Chemistry. 2014 May;57(10):4009-4022.
2014-05	High expression of Hsp90-beta and GRP 94 association with poor survival in resected non-small cell lung cancer patients	Journal of Clinical Oncology. 2014 May;32(15, Suppl.):e13522.
2014-04	Antimitotic and vascular disrupting agents: 2-hydroxy-3,4,5-trimethoxybenzophenones	European Journal of Medicinal Chemistry. 2014 Apr 22;77(2):306-314.

顯示項目26-50 / 55. (共3頁) << < 1 2 3 > >> 每頁顯示[10|25|50]項目